Why there's excitement and skepticism about new Alzheimer's drug lecanemab
Despite decades of research and billions of dollars, no treatment has ever definitively proven to slow the progression of Alzheimer’s disease. Two pharmaceutical companies have developed a drug that they say does just that.
Post a Comment